Literature DB >> 2984719

Hepatic tumors: differentiation by transverse relaxation time (T2) of magnetic resonance imaging.

K Ohtomo, Y Itai, S Furui, N Yashiro, K Yoshikawa, M Iio.   

Abstract

Fifty-three patients who had hepatic tumors (24 hepatomas, ten metastases, and 19 cavernous hemangiomas) underwent MR imaging using a 0.35-T superconducting imager. The transverse relaxation time (T2) was calculated from a pair of spin echo images (repetition time [TR] of 1600 msec) with echo delay times (TE) of 35 and 70 msec. The computed T2 value was obtained in a fashion similar to that used to obtain CT numbers with region-of-interest cursors. The mean T2 was 59 +/- 9 msec in hepatomas, 64 +/- 15 msec in metastases, and 100 +/- 30 msec in hemangiomas. The difference between the T2 of hemangioma and that of liver malignancies was statistically significant (P less than .001); however, differentiation between hepatoma and metastases was not possible. The T2 was shorter than 80 msec in all 24 hepatomas and in nine of ten metastases, and was longer than 80 msec in 16 of 19 hemangiomas. Forty-nine of 53 cases (92%) were correctly classified when the borderline of T2 between hemangioma and hepatic malignancies was set at 80 msec. MR with T2 calculation was valuable in differentiating between hemangioma and hepatic malignancies.

Entities:  

Mesh:

Year:  1985        PMID: 2984719     DOI: 10.1148/radiology.155.2.2984719

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  8 in total

1.  Giant cavernous hemangiomas: diagnosis and surgical strategies.

Authors:  M Lise; G Feltrin; P P Da Pian; D Miotto; P L Pilati; L Rubaltelli; D Zane
Journal:  World J Surg       Date:  1992 May-Jun       Impact factor: 3.352

2.  MR imaging in hydatid disease of the liver.

Authors:  F L Hoff; A M Aisen; M E Walden; G M Glazer
Journal:  Gastrointest Radiol       Date:  1987

3.  Preliminary experience with a new double-echo half-Fourier single-shot turbo spin echo acquisition in the characterization of liver lesions.

Authors:  H Bosmans; S Gryspeerdt; L Van Hoe; S Van Oostende; T De Jaegere; B Kiefer; A L Baert; G Marchal
Journal:  MAGMA       Date:  1997-03       Impact factor: 2.310

4.  Differentiation of hepatic tumors by use of image contrast with T2-weighted MRI.

Authors:  Akio Ogura; Katsumi Hayakawa; Tosiaki Miyati; Fumie Maeda; Akira Miyai; Fumito Saeki; Takaharu Murata
Journal:  Radiol Phys Technol       Date:  2008-11-11

5.  Ultrasound, CT, and MRI comparison in primary and secondary tumors of the liver.

Authors:  W L Curati; A Halevy; R N Gibson; D H Carr; L H Blumgart; R E Steiner
Journal:  Gastrointest Radiol       Date:  1988

6.  MR findings of hepatic cavernous hemangioma after intraarterial infusion of iodized oil.

Authors:  B I Choi; Y M Shin; J W Chung; S H Kim; J H Park; M C Han
Journal:  Abdom Imaging       Date:  1994 Nov-Dec

7.  MRI to assess chemoprevention in transgenic adenocarcinoma of mouse prostate (TRAMP).

Authors:  Ali S Arbab; Adarsh Shankar; Nadimpalli R S Varma; Dorrah Deeb; Xiaohua Gao; A S M Iskander; Branislava Janic; Meser M Ali; Subhash C Gautam
Journal:  BMC Med Imaging       Date:  2011-12-13       Impact factor: 1.930

Review 8.  Distinguishing benign from malignant liver tumours.

Authors:  Jay P Heiken
Journal:  Cancer Imaging       Date:  2007-10-01       Impact factor: 3.909

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.